Inflammation as a New Therapeutic Target among Older Patients with Ischemic Heart Disease.
Daniela MaidanaAndrea Arroyo-ÁlvarezAndrea Arenas-LorienteGuillermo Barreres-MartínCarles Muñoz-AlfonsoDaznia Bompart BerroteránFrancisca Esteve ClaramuntRegina Blanco Del BurgoPedro Luis Cepas-GuillenSergio Garcia-BlasClara BonanadPublished in: Journal of clinical medicine (2024)
Cardiovascular (CV) diseases remain a global health challenge, with ischemic heart disease (IHD) being the primary cause of both morbidity and mortality. Despite optimal pharmacological therapy, older patients with IHD exhibit an increased susceptibility to recurrent ischemic events, significantly impacting their prognosis. Inflammation is intricately linked with the aging process and plays a pivotal role in the evolution of atherosclerosis. Emerging anti-inflammatory therapies have shown promise in reducing ischemic events among high-risk populations. This review aims to explore the potential of targeted anti-inflammatory interventions in improving clinical outcomes and the quality of life for older patients with IHD.